Joe Biden, National Security Adviser, said on Sunday that the United States will send components to produce a vaccine and medical equipment “immediately” to India in light of the increase in cases of coronavirus.
Also read: Thirty-one problematic flight from India
“The United States has identified the origin of certain components necessary to produce anti-virus vaccines in India that will be immediately available to India,” Jake Sullivan said in a statement. Until now exports of these components have been restricted by the United States government.
Washington is also preparing to urgently dispatch to India “medicines, rapid diagnostic tests, ventilators, and protective equipment” and deploy experts from the US Centers for Disease Control and Prevention (CDC), the persistent Sullivan, who spoke with his Indian counterpart on Sunday.
The United States is also studying the possibility of sending oxygen supplies, as Indian hospitals face serious shortages in this regard.
The White House adviser noted that the Biden administration is already funding India’s vaccine production capacity “substantially” so that the country can produce 1 billion doses of the COVID-19 vaccine by the end of 2022.
“Just as India provided assistance to the United States when our hospitals were overwhelmed at the start of the pandemic, so the United States is determined to help India when it needs it,” Sullivan said.
The announcement comes after many countries and the European Union pledged on Sunday to provide emergency aid to India, which on Sunday recorded nearly 350,000 cases and 2,767 additional deaths over a 24-hour period.
France, in particular, promised “substantial support in oxygen capacity” and the United Kingdom, more than 600 emergency medical equipment, including ventilators.
However, the US government did not discuss sending vaccines to India as political pressure intensified over the issue.
Earlier on Sunday, White House Medical Adviser Anthony Fauci had nonetheless contemplated the possibility of delivering tens of millions of doses of AstraZeneca serum to India.
This stock is held by the United States government, and a vaccine from the Anglo-Swedish laboratory has yet to be authorized by the US health authorities.
“This is something that will be seriously looked at,” Anthony Fauci told ABC.
He admitted that “we must do more” to help India, explaining that the United States is studying how to “provide vaccines immediately”, as well as how to allow Indians “to produce their own vaccines.”
The United States, under President Donald Trump, has put in place an executive order called the Defense Production Act, which requires Americans to have priority over vaccines manufactured in their country and de facto restrict exports of doses manufactured in the United States. Also the ingredients.
“The United States is primarily engaged in an ambitious and effective campaign to vaccinate all Americans,” said US diplomatic spokesman Ned Price.
India, with a population of 1.3 billion and where the new alternative is spreading, sees its health system cracking under the deluge of patients, who face shortages of hospital beds, oxygen reserves and life-saving medicines.
Witnesses described hospital corridors filled with beds, stretchers, and families begging in vain for oxygen or a place for their dying loved ones.
The world’s largest vaccine manufacturer, the Serum Institute of India (SII) located in India, warned in mid-April that it was restricting its access to certain ingredients from the United States necessary for the production of large quantities of new vaccines.
“Respected President Biden, if we are truly united in fighting this virus, on behalf of vaccine manufacturers outside the United States, I humbly ask you to lift the ban on exports of raw ingredients,” said Adar Bunawala, Director of the Strategic Impact Inquiry.